Table 2.
Factor | Condition | SR; n (%) | non-SR; n (%) | p-value | OR for SR (95%CI) | OR for non-SR (95% CI) |
---|---|---|---|---|---|---|
IFNL3 | CC | 45 (61.6) | 28 (38.4) | <0.001 | 7.1 (3.23 to 15.81) | 1 |
Non-CC | 12 (18.5) | 53 (81.5) | 1 | 0.14 (0.06 to 0.33) | ||
HLA-B*44 | Absence | 41 (43.6) | 53 (56.4) | 0.037 | 2.65 (1.06 to 7.17) | 1 |
Presence | 7 (22.6) | 24 (77.4) | 1 | 0.38 (0.14 to 0.95) | ||
HLA-C*07 | Absence | 39 (46.4) | 45 (53.6) | 0.028 | 2.71 (1.10 to 7) | 1 |
Presence | 8 (24.2) | 25 (75.8) | 1 | 0.37 (0.14 to 0.91) | ||
HLA-C*12 | Absence | 44 (45.8) | 52 (54.2) | 0.008 | 5.08 (1.49 to 22.6) | 1 |
Presence | 3 (14.3) | 18 (85.7) | 1 | 0.20 (0.04 to 0.67) | ||
KIR3DS1 | Absence | 50 (47.6) | 55 (52.4) | <0.001 | 5.68 (1.94 to 20.05) | 1 |
Presence | 4 (13.8) | 25 (86.2) | 1 | 0.18 (0.05 to 0.52) |
Abbreviations: spontaneous resolution (SR); non-spontaneous resolution (non-SR); n (number of cases); 95% confidence interval (95% CI); odds ratio (OR).